Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp. reports developments tied to crop productivity technologies for agricultural markets, including seeds, seed traits, seed treatments, biologicals, adjuvants, fertilizers, crop protection products and crop nutrition. Its recurring updates focus on operating results across crop protection, seed and integrated products, and crop nutrition, with frequent discussion of product mix, margins, working-capital discipline and conditions in Argentina.
Bioceres also announces collaboration and commercialization activity for HB4 wheat, a trait platform positioned for climate-resilient wheat production, as well as updates on capital structure matters and asset-related disputes affecting the business. Bioceres presents financial results under IFRS and regularly schedules calls around quarterly and full-year reporting periods.
Bioceres Crop Solutions (NASDAQ:BIOX) reported 3Q26 revenue of $39.4 million, down 23% year over year, driven by softer Crop Protection demand and a transition in Seeds toward an asset-light model. Crop Nutrition revenue grew 15%.
Gross profit was $12.7 million with a 32% margin, impacted by product mix and a non-recurring inoculant obsolescence adjustment. Net loss was $10.0 million and Adjusted EBITDA was $(0.6) million. SG&A expenses declined 16% as the company advanced organizational streamlining, working capital improvements, liability management, and a voluntary bond maturity extension in Argentina. Pro Farm Group was classified as discontinued operations following a foreclosure auction and related litigation.
Bioceres Crop Solutions (NASDAQ: BIOX) will host its fiscal third quarter 2026 results conference call on Tuesday, May 12, 2026 at 8:30 a.m. ET to discuss results for the quarter ended March 31, 2026.
The call will be led by CEO Federico Trucco, CFO Ezequiel Simmermacher, and Head of IR Paula Savanti, include a presentation and Q&A, and will be webcast with replay available on the company investor relations website. Dial-in and conference ID 925241 are provided for participation.
Summary not available.
Bioceres Crop Solutions (NASDAQ: BIOX) reported Q2 fiscal 2026 results for the six months ended Dec 31, 2025, highlighting a $179 million impairment after a $15 million foreclosure bid on Pro Farm assets carried at ~$194 million. Continuing operations in Argentina delivered a 40% gross margin YTD.
The company disclosed substantial doubt about going concern, is pursuing legal remedies regarding the Pro Farm foreclosure, is negotiating with noteholders, and is pursuing refinancing, asset disposal and a three-year plan to restore profitability and cash flow.
Bioceres Crop Solutions (NASDAQ: BIOX) reported fiscal 1Q26 results for the quarter ended September 30, 2025. Total revenues were $77.5 million, down 17% YoY as the company reduced low-margin, working-capital-intensive sales and completed a seed-model transition. Gross profit was $36.2 million and gross margin expanded to 46.7% from 40.2% (651 bps). Adjusted EBITDA rose to $13.6 million (+61% YoY) while GAAP net loss was $7.5 million versus a $6.2 million loss a year earlier. Management highlighted margin improvement and cost discipline.
Bioceres Crop Solutions (NASDAQ: BIOX) will host its fiscal first quarter 2026 earnings conference call on Thursday, November 13, 2025 at 8:30 a.m. ET to discuss results for the quarter ended September 30, 2025. A press release with results will be issued prior to the call.
Bioceres Chairman & CEO Federico Trucco and Head of Investor Relations Paula Savanti will host the call, which includes a presentation available via webcast and an investor relations page. Replay will be available through November 20, 2025.
Bioceres Crop Solutions (NASDAQ: BIOX) has formed a strategic partnership with the Colorado Wheat Research Foundation (CWRF) to develop and commercialize HB4® wheat in the United States. Through this collaboration, CWRF will receive exclusive, sublicensable rights to the HB4® trait in the U.S. and serve as Trait Manager.
The partnership aims to create a next-generation wheat production system combining climate resilience with sustainable weed management. The companies will jointly develop new broad-spectrum herbicide formulations specifically for HB4® wheat, integrated with Bioceres' biological solutions. Bioceres will maintain leadership of regulatory activities while ensuring alignment with U.S. Wheat Industry Principles for Biotechnology Commercialization.
The HB4® trait will be available through an open licensing model to all interested public and private wheat breeding programs in the U.S.Bioceres Crop Solutions (NASDAQ: BIOX) reported challenging financial results for Q4 and FY2025. Total revenues declined to $74.7 million in Q4 (-40% YoY) and $335.3 million for FY25 (-28% YoY), primarily due to weaker demand in Argentina and lower HB4-related sales.
The company reported a Q4 net loss of $48.0 million and FY25 net loss of $55.2 million. Despite profitability challenges, net cash flow from operations improved by 27% YoY to $53.0 million in FY25. The company maintained a relatively stable full-year gross margin at 39%, supported by higher-value proprietary products.
In response, management is implementing cost-cutting measures, targeting 10-12% operating expense savings and reducing CAPEX and R&D investment rates by 50% to 2.5-3% of sales for FY26 and FY27.
Bioceres Crop Solutions (NASDAQ: BIOX), a company focused on agricultural ecosystem regeneration and climate-resilient crop solutions, has scheduled its fiscal fourth quarter and full year 2025 financial results conference call for Tuesday, September 9, 2025, at 8:30 a.m. ET.
The conference call will be hosted by CEO Federico Trucco and Head of IR Paula Savanti, featuring a presentation and Q&A session. Financial results will be released before the call, with presentation materials available through the company's investor relations website. A replay will be accessible until September 16, 2025.